429 related articles for article (PubMed ID: 31400638)
1. Interleukin-4 and interleukin-13 as possible therapeutic targets in systemic sclerosis.
Gasparini G; Cozzani E; Parodi A
Cytokine; 2020 Jan; 125():154799. PubMed ID: 31400638
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis.
Fuschiotti P; Larregina AT; Ho J; Feghali-Bostwick C; Medsger TA
Arthritis Rheum; 2013 Jan; 65(1):236-46. PubMed ID: 23001877
[TBL] [Abstract][Full Text] [Related]
3. Induction of Inflammation and Fibrosis by Semaphorin 4A in Systemic Sclerosis.
Carvalheiro T; Affandi AJ; Malvar-Fernández B; Dullemond I; Cossu M; Ottria A; Mertens JS; Giovannone B; Bonte-Mineur F; Kok MR; Marut W; Reedquist KA; Radstake TR; García S
Arthritis Rheumatol; 2019 Oct; 71(10):1711-1722. PubMed ID: 31012544
[TBL] [Abstract][Full Text] [Related]
4. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
[TBL] [Abstract][Full Text] [Related]
5. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
Fuschiotti P; Medsger TA; Morel PA
Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis.
MacDonald KG; Dawson NAJ; Huang Q; Dunne JV; Levings MK; Broady R
J Allergy Clin Immunol; 2015 Apr; 135(4):946-955.e9. PubMed ID: 25678090
[TBL] [Abstract][Full Text] [Related]
7. T cells in systemic sclerosis: a reappraisal.
O'Reilly S; Hügle T; van Laar JM
Rheumatology (Oxford); 2012 Sep; 51(9):1540-9. PubMed ID: 22577083
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis.
Denton CP; Ong VH; Xu S; Chen-Harris H; Modrusan Z; Lafyatis R; Khanna D; Jahreis A; Siegel J; Sornasse T
Ann Rheum Dis; 2018 Sep; 77(9):1362-1371. PubMed ID: 29853453
[TBL] [Abstract][Full Text] [Related]
9. Fibrosis and immune dysregulation in systemic sclerosis.
Chizzolini C; Brembilla NC; Montanari E; Truchetet ME
Autoimmun Rev; 2011 Mar; 10(5):276-81. PubMed ID: 20863906
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-31 promotes fibrosis and T helper 2 polarization in systemic sclerosis.
Kuzumi A; Yoshizaki A; Matsuda KM; Kotani H; Norimatsu Y; Fukayama M; Ebata S; Fukasawa T; Yoshizaki-Ogawa A; Asano Y; Morikawa K; Kazoe Y; Mawatari K; Kitamori T; Sato S
Nat Commun; 2021 Oct; 12(1):5947. PubMed ID: 34642338
[TBL] [Abstract][Full Text] [Related]
11. STAT6 suppression prevents bleomycin-induced dermal fibrosis.
Huang J; Puente H; Wareing NE; Wu M; Mayes MD; Karmouty-Quintana H; Assassi S; Mills TW
FASEB J; 2023 Feb; 37(2):e22761. PubMed ID: 36629780
[TBL] [Abstract][Full Text] [Related]
12. Potential roles of interleukin-17A in the development of skin fibrosis in mice.
Okamoto Y; Hasegawa M; Matsushita T; Hamaguchi Y; Huu DL; Iwakura Y; Fujimoto M; Takehara K
Arthritis Rheum; 2012 Nov; 64(11):3726-35. PubMed ID: 22833167
[TBL] [Abstract][Full Text] [Related]
13. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
[TBL] [Abstract][Full Text] [Related]
14. T follicular helper-like cells contribute to skin fibrosis.
Taylor DK; Mittereder N; Kuta E; Delaney T; Burwell T; Dacosta K; Zhao W; Cheng LI; Brown C; Boutrin A; Guo X; White WI; Zhu J; Dong H; Bowen MA; Lin J; Gao C; Yu L; Ramaswamy M; Gaudreau MC; Woods R; Herbst R; Carlesso G
Sci Transl Med; 2018 Mar; 10(431):. PubMed ID: 29514998
[TBL] [Abstract][Full Text] [Related]
15. Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells.
Saigusa R; Asano Y; Taniguchi T; Hirabayashi M; Nakamura K; Miura S; Yamashita T; Takahashi T; Ichimura Y; Toyama T; Yoshizaki A; Trojanowska M; Sato S
Arthritis Res Ther; 2018 Feb; 20(1):23. PubMed ID: 29415756
[TBL] [Abstract][Full Text] [Related]
16. Baricitinib Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating the Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway.
Dang C; Lu Y; Chen X; Li Q
Front Immunol; 2021; 12():650708. PubMed ID: 33927721
[TBL] [Abstract][Full Text] [Related]
17. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts.
Nakashima T; Jinnin M; Yamane K; Honda N; Kajihara I; Makino T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
J Immunol; 2012 Apr; 188(8):3573-83. PubMed ID: 22403442
[TBL] [Abstract][Full Text] [Related]
18. Anti-IL-4 treatment prevents dermal collagen deposition in the tight-skin mouse model of scleroderma.
Ong C; Wong C; Roberts CR; Teh HS; Jirik FR
Eur J Immunol; 1998 Sep; 28(9):2619-29. PubMed ID: 9754550
[TBL] [Abstract][Full Text] [Related]
19. Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts.
Raschi E; Chighizola CB; Cesana L; Privitera D; Ingegnoli F; Mastaglio C; Meroni PL; Borghi MO
Arthritis Res Ther; 2018 Aug; 20(1):187. PubMed ID: 30157947
[TBL] [Abstract][Full Text] [Related]
20. 14-3-3z sequesters cytosolic T-bet, upregulating IL-13 levels in T
Cascio S; Medsger TA; Hawse WF; Watkins SC; Milcarek C; Moreland LW; Lafyatis RA; Fuschiotti P
J Allergy Clin Immunol; 2018 Jul; 142(1):109-119.e6. PubMed ID: 29155097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
